Ozempic Face and Mounjaro Face: What Happens to Your Skin and How to Treat It

Written by Liona Harris, HCPC-Registered Physiotherapist and Lead Aesthetic Practitioner, Skin Revive Aesthetics, Lancaster. Last updated: October 2026.

If you have lost significant weight on a GLP-1 medication such as Ozempic, Wegovy, or Mounjaro and noticed that your face looks older, hollower, or more tired than before, you are not imagining it. This is a well-documented pattern, commonly referred to as Ozempic face or Mounjaro face, and it is one of the most common concerns I see in clinic at Skin Revive Aesthetics in Lancaster.

The good news: the changes are not permanent, and there are effective clinical approaches designed specifically to address them.

This article explains what Ozempic face is, why it happens, what the skin changes look like, and what the current treatment options are — including the Restore Protocol, a structured 12-week programme developed at Skin Revive Aesthetics in direct response to what was presenting in clinic.

What Is Ozempic Face?

Ozempic face is the informal term for the collection of facial changes that can occur following significant or rapid weight loss on GLP-1 receptor agonist medications. The term entered widespread use around 2022 as semaglutide (the active ingredient in Ozempic and Wegovy) became more widely prescribed in the UK and internationally. The equivalent term for tirzepatide users taking Mounjaro is Mounjaro face.

The name is slightly misleading, because the drug itself is not directly responsible for most of the skin changes. The mechanism is primarily driven by the weight loss it produces, particularly when that loss is rapid or substantial.

In clinical terms, Ozempic face refers to:

• Facial hollowing — loss of volume in the mid-face, temples, and under-eye area

• Skin laxity — reduced firmness and increased looseness of the facial skin

• Textural deterioration — changes in skin quality, including crepiness, dryness, and loss of radiance

• Under-eye changes — deepening of the tear trough, appearance of hollowing beneath the eyes

• Loss of structural definition — reduced jawline definition, jowling, general loss of facial architecture

Not everyone who loses weight on a GLP-1 medication will experience all of these changes, and their severity varies considerably depending on the speed and volume of weight loss, age, skin quality before treatment, and genetics.

Why Does GLP-1 Weight Loss Affect the Face?

Facial fat exists in discrete compartments — small, anatomically distinct pockets that give the face its three-dimensional shape. These fat pads are not incidental padding; they are the scaffolding on which the overlying skin rests. When facial fat volume decreases, the skin loses its support, which is why facial hollowing and skin laxity tend to appear together rather than separately.

GLP-1 medications produce their weight-loss effect through a combination of reduced appetite, slowed gastric emptying, and altered metabolic signalling. The weight loss they produce tends to be relatively rapid, and rapid fat loss is associated with greater facial change because the skin has less time to adapt through its own remodelling processes.

1. Superficial Fat Pad Loss

The cheeks, temples, and periorbital areas rely heavily on superficial fat pads for their volume. These are among the first areas to deflate during significant weight loss. When they do, the overlying skin does not retract proportionately — it folds and sags, producing the characteristic hollow, gaunt appearance that patients describe.

2. Collagen and Elastin Disruption

Rapid weight loss is associated with measurable reductions in collagen density and elastin quality in the dermis. Collagen provides the structural matrix that keeps skin firm; elastin gives it the capacity to spring back. When both are diminished, the skin creases more readily, recovers more slowly, and loses the suppleness that reads as youthful.

3. Reduced Skin Elasticity

Skin elasticity declines naturally with age, but rapid weight change accelerates this process by placing sudden mechanical demand on skin that has not had time to adapt. In patients who lost weight quickly on GLP-1 medication — particularly those already in their 40s or 50s — this can produce a degree of laxity that the skin's own recovery mechanisms will not fully resolve without clinical support.

What Does Ozempic Face Look Like?

The most common presentations in clinic are hollowing in the cheeks and temples, where patients describe looking drawn or much older even though the rest of their body looks healthier. Under-eye changes are also common, with the tear trough deepening and the under-eye area appearing dark, hollow, or shadowed.

Skin quality changes — drier, less radiant, more textured skin — frequently accompany the structural changes. Jowling and loss of jawline definition occur when the overlying skin descends as facial fat is lost. These changes vary enormously between individuals and clinical assessment is essential before any treatment plan is designed.

Can Ozempic Face Be Prevented?

Some degree of facial change during significant weight loss is likely unavoidable. However, there is emerging clinical consensus that starting skin-supportive treatments during the weight-loss phase may help mitigate the severity of laxity and collagen loss. The rationale is that treatments which stimulate collagen production and skin remodelling can support the skin's structural integrity as it adapts to the changes happening beneath it.

Treatment Options for Ozempic Face

What is required, in most cases, is a multi-modal approach — one that simultaneously addresses volume loss, collagen depletion, skin laxity, and textural deterioration.

Dermal Fillers

Hyaluronic acid fillers can be effective for specific, localised volume restoration — particularly in the tear trough and cheek area. However, they have significant limitations as a standalone solution. Volume restoration with filler does not address the underlying skin quality issues. Many experienced practitioners now recommend treating skin quality and laxity first, and reassessing volume needs afterwards.

RF Microneedling

Radiofrequency microneedling is one of the most evidence-supported non-surgical approaches to skin laxity and collagen remodelling. The treatment delivers radiofrequency energy into the dermis via fine needles, creating controlled thermal injury at depth. This stimulates the fibroblasts responsible for collagen and elastin production, initiating a remodelling cascade that continues for months after treatment.

HIFU (High-Intensity Focused Ultrasound)

HIFU works at a deeper level than RF microneedling, targeting the SMAS layer beneath the dermis and above the deeper facial muscles. By delivering focused ultrasound energy to this layer, HIFU stimulates collagen production and produces a lifting and tightening effect. For patients with significant skin laxity — particularly jowling and loss of jawline definition — HIFU can be a valuable component of a treatment plan.

Polynucleotides

Polynucleotides are fragments of purified DNA, derived from salmon sperm — the origin of the salmon DNA facial term. When injected intradermally, they stimulate fibroblast activity, promote hydration, and support the skin's own repair and renewal processes. Unlike fillers, polynucleotides work at a cellular level to improve the quality of the tissue itself.

Near-Infrared Light and Bipolar RF

These modalities deliver targeted energy into the dermis to stimulate collagen production and improve skin quality without the downtime associated with needling. They are particularly effective for skin tone, texture, and mild laxity, and are well suited to patients who need to return to normal activities immediately after treatment.

The Restore Protocol: A Structured Clinical Answer

The Restore Protocol is a 12-week clinical programme at Skin Revive Aesthetics, Lancaster, combining four modalities — RF Microneedling, Near-Infrared Light, Bipolar RF, and Fractional RF — across 12 treatments. It was developed in direct response to patients who had achieved meaningful results with GLP-1 medication but were experiencing facial changes that standard single-treatment approaches were not adequately addressing.

The programme is structured in three phases. Phase 1 (Weeks 1-4): Foundation — Near-Infrared Light and Bipolar RF treatments begin stimulating collagen production and preparing the tissue for more intensive treatment. Phase 2 (Weeks 5-8): Remodelling — RF Microneedling targets skin laxity and dermal firming, with Fractional RF addressing texture and surface quality. Phase 3 (Weeks 9-12): Consolidation — treatments support the remodelling gains of Phase 2 and address any residual concerns.

The programme is priced at £1,035 in full, with monthly payment plans available at £345 per month at no additional cost. A free, no-obligation 30-minute consultation precedes every programme.

Why Clinical Background Matters

Liona Harris is an HCPC-registered physiotherapist with 15 years of clinical healthcare experience. The HCPC (Health and Care Professions Council) is the UK's statutory regulator for allied health professionals. HCPC registration means practice is governed by statutory standards of proficiency, conduct, and continuing professional development — a different level of regulatory accountability from that which applies to many aesthetic practitioners.

When assessing a patient for the Restore Protocol or any other treatment, the process begins with a full clinical assessment: reviewing health history, medications, skin condition, and anatomical presentation. The treatment plan that follows is built on that assessment, not on a standard protocol applied uniformly.

Frequently Asked Questions About Ozempic Face

What is Ozempic face? Ozempic face is the informal term for the facial changes — including hollowing, skin laxity, textural deterioration, and under-eye changes — that can occur following significant weight loss on GLP-1 medications such as Ozempic, Wegovy, or Mounjaro. The changes are primarily driven by rapid fat pad loss and the associated reduction in collagen density.

Is Ozempic face permanent? No. The changes are not permanent. Facial fat pads can be partially restored through volume-replacement treatments, and collagen production can be stimulated through RF microneedling, HIFU, polynucleotides, and other regenerative treatments.

Does filler fix Ozempic face? Filler can address specific, localised volume loss but does not address the skin quality changes: the laxity, crepiness, and collagen depletion. Most experienced practitioners recommend treating skin quality and laxity first, then reassessing volume needs.

How much does post-GLP-1 skin treatment cost in the UK? Individual RF microneedling sessions typically range from £200 to £350. The Restore Protocol at Skin Revive Aesthetics is £1,035 for the full 12-week programme, with monthly payment plans available at £345 per month.

Book a Free Restore Protocol Consultation

Liona offers a free 30-minute Restore Protocol consultation at Skin Revive Aesthetics, 3-1-5 Health Club, Mannin Way, Lancaster, LA1 3PE. Book at skinreviveaesthetics.com, email info@skinreviveaesthetics.com, or call +44 7713148723.